Applied DNA Sciences, Inc.
APDN
$0.862
-$0.0018-0.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.74M | 3.43M | 3.40M | 5.52M | 9.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.74M | 3.43M | 3.40M | 5.52M | 9.00M |
| Cost of Revenue | 2.27M | 2.41M | 2.55M | 3.64M | 5.61M |
| Gross Profit | 1.47M | 1.02M | 851.00K | 1.88M | 3.39M |
| SG&A Expenses | 11.00M | 11.45M | 12.07M | 12.69M | 13.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.94M | 17.46M | 18.32M | 19.95M | 22.52M |
| Operating Income | -13.20M | -14.02M | -14.92M | -14.44M | -13.52M |
| Income Before Tax | -8.63M | -7.09M | -7.39M | -12.35M | -7.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.63 | -7.09 | -7.39 | -12.35 | -7.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 99.90K | 95.80K | 102.20K | 86.30K | 100.20K |
| Net Income | -8.53M | -6.99M | -7.29M | -12.27M | -7.21M |
| EBIT | -13.20M | -14.02M | -14.92M | -14.44M | -13.52M |
| EBITDA | -12.74M | -13.33M | -13.98M | -13.27M | -12.20M |
| EPS Basic | -285.88 | -344.55 | -593.29 | -856.83 | -545.80 |
| Normalized Basic EPS | -157.63 | -204.85 | -359.42 | -523.86 | -334.45 |
| EPS Diluted | -285.88 | -344.55 | -593.29 | -856.83 | -545.80 |
| Normalized Diluted EPS | -157.63 | -204.85 | -359.42 | -523.86 | -334.45 |
| Average Basic Shares Outstanding | 934.10K | 317.40K | 125.00K | 57.60K | 53.10K |
| Average Diluted Shares Outstanding | 934.10K | 317.40K | 125.00K | 57.60K | 53.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |